MRI fusion-guided biopsy is the latest technology which
helps accurately target specific suspicious areas in
the prostate for cancer. This technology provides a higher probably
that a significant lesion is not missed during
biopsy procedure and will lessen the need for repeat biopsies for
patients. For patients this means less risk, early prostate cancer detection
and the earlier the detection
the higher percentage to cure early.
MRI fusion-guided biopsies fuses together pictures from magnetic
resonance imaging (MRI) and combined with real time ultrasound to create a, three-dimensional
view of the prostate, which the physician can then do accurate
biopsies. Introduction of this product was the result of
nearly a decade of research and development, principally conducted at
the National Cancer Institute.
Other than skin cancer, prostate cancer has become the most common
form of cancer in America for men and the second-leading cause of cancer
death in this population.
MRI fusion-guided biopsy is poised to become the diagnosis standard
for prostate cancer detection.
For a consultation please click the link below to
schedule an appointment now!